Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective

Drug development in lupus has improved over the past 10 years but still lags behind that of other rheumatic disease areas. Assessment of prospective lupus therapies in clinical trials has proved challenging for reasons that are multifactorial including the heterogeneity of the disease, study design...

Descripción completa

Detalles Bibliográficos
Autores principales: Buie, Joy, Bloch, Lauren, Morand, Eric F, van Vollenhoven, Ronald F, Werth, Victoria P, Touma, Zahi, Lipsky, Peter, Kalunian, Kenneth, Askanase, Anca D, Ines, L, Reed, Christopher, Son, MaryBeth, Franson, Timothy, Costenbader, Karen, Schanberg, Laura Eve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930541/
https://www.ncbi.nlm.nih.gov/pubmed/37537705
http://dx.doi.org/10.1136/lupus-2023-000901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930541/
https://www.ncbi.nlm.nih.gov/pubmed/37537705
http://dx.doi.org/10.1136/lupus-2023-000901

Ejemplares similares